Cargando…

Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review

BACKGROUND: Legacy—what one leaves behind and how one hopes to be remembered after death—is an unexplored and important dimension of decision-making for people facing serious illnesses. A preliminary literature review suggests that patients facing serious illness consider legacy when making medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueroa Gray, Marlaine, Banegas, Matthew P, Henrikson, Nora B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789496/
https://www.ncbi.nlm.nih.gov/pubmed/36485023
http://dx.doi.org/10.2196/40791
_version_ 1784858968243306496
author Figueroa Gray, Marlaine
Banegas, Matthew P
Henrikson, Nora B
author_facet Figueroa Gray, Marlaine
Banegas, Matthew P
Henrikson, Nora B
author_sort Figueroa Gray, Marlaine
collection PubMed
description BACKGROUND: Legacy—what one leaves behind and how one hopes to be remembered after death—is an unexplored and important dimension of decision-making for people facing serious illnesses. A preliminary literature review suggests that patients facing serious illness consider legacy when making medical decisions, for example, forgoing expensive treatment with limited or unknown clinical benefit to preserve one’s inheritance for their children. To date, very little is known about the conceptual foundations of legacy. No conceptual frameworks exist that provide a comprehensive understanding of how legacy considerations relate to patient choices about their medical care. OBJECTIVE: The objective of this scoping review is to understand the extent and type of research addressing the concept of legacy by people facing serious illness to inform a conceptual framework of legacy and patient treatment choices. METHODS: This protocol follows the guidelines put forth by Levac et al, which expands the framework introduced by Arksey and O’Malley, as well as the Joanna Briggs Institute Reviewer’s manual. This scoping review will explore several electronic databases including PubMed, Medline, CINAHL, Cochrane Library, PsycINFO, and others and will include legacy-specific gray literature, including dissertation research available via ProQuest. An initial search will be conducted in English-language literature from 1990 to the present with selected keywords to identify relevant articles and refine the search strategy. After the search strategy has been finalized, 2 independent reviewers will undertake a 2-part study selection process. In the first step, reviewers will screen article titles and abstracts to identify the eligibility of each article based on predetermined exclusion or inclusion criteria. A third senior reviewer will arbitrate discrepancies regarding inclusions or exclusions. During the second step, the full texts will be screened by 2 reviewers, and only relevant articles will be kept. Relevant study data will be extracted, collated, and charted to summarize the key findings related to the construct of legacy. RESULTS: This study will identify how people facing serious illness define legacy, and how their thinking about legacy impacts the choices they make about their medical treatments. We will note gaps in the literature base. The findings of this study will inform a conceptual model that outlines how ideas about legacy impact the patient’s treatment choices. The results of this study will be submitted to an indexed journal. CONCLUSIONS: Very little is known about the role of legacy in the treatment decisions of patients across the continuum of serious illness. In particular, no comprehensive conceptual model exists that would provide an understanding of how legacy is considered by people making decisions about their care during serious illness. This study will be among the first to construct a conceptual model detailing how considerations of legacy impact medical decision-making for people facing or living with serious illnesses. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/40791
format Online
Article
Text
id pubmed-9789496
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-97894962022-12-25 Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review Figueroa Gray, Marlaine Banegas, Matthew P Henrikson, Nora B JMIR Res Protoc Protocol BACKGROUND: Legacy—what one leaves behind and how one hopes to be remembered after death—is an unexplored and important dimension of decision-making for people facing serious illnesses. A preliminary literature review suggests that patients facing serious illness consider legacy when making medical decisions, for example, forgoing expensive treatment with limited or unknown clinical benefit to preserve one’s inheritance for their children. To date, very little is known about the conceptual foundations of legacy. No conceptual frameworks exist that provide a comprehensive understanding of how legacy considerations relate to patient choices about their medical care. OBJECTIVE: The objective of this scoping review is to understand the extent and type of research addressing the concept of legacy by people facing serious illness to inform a conceptual framework of legacy and patient treatment choices. METHODS: This protocol follows the guidelines put forth by Levac et al, which expands the framework introduced by Arksey and O’Malley, as well as the Joanna Briggs Institute Reviewer’s manual. This scoping review will explore several electronic databases including PubMed, Medline, CINAHL, Cochrane Library, PsycINFO, and others and will include legacy-specific gray literature, including dissertation research available via ProQuest. An initial search will be conducted in English-language literature from 1990 to the present with selected keywords to identify relevant articles and refine the search strategy. After the search strategy has been finalized, 2 independent reviewers will undertake a 2-part study selection process. In the first step, reviewers will screen article titles and abstracts to identify the eligibility of each article based on predetermined exclusion or inclusion criteria. A third senior reviewer will arbitrate discrepancies regarding inclusions or exclusions. During the second step, the full texts will be screened by 2 reviewers, and only relevant articles will be kept. Relevant study data will be extracted, collated, and charted to summarize the key findings related to the construct of legacy. RESULTS: This study will identify how people facing serious illness define legacy, and how their thinking about legacy impacts the choices they make about their medical treatments. We will note gaps in the literature base. The findings of this study will inform a conceptual model that outlines how ideas about legacy impact the patient’s treatment choices. The results of this study will be submitted to an indexed journal. CONCLUSIONS: Very little is known about the role of legacy in the treatment decisions of patients across the continuum of serious illness. In particular, no comprehensive conceptual model exists that would provide an understanding of how legacy is considered by people making decisions about their care during serious illness. This study will be among the first to construct a conceptual model detailing how considerations of legacy impact medical decision-making for people facing or living with serious illnesses. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/40791 JMIR Publications 2022-12-09 /pmc/articles/PMC9789496/ /pubmed/36485023 http://dx.doi.org/10.2196/40791 Text en ©Marlaine Figueroa Gray, Matthew P Banegas, Nora B Henrikson. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 09.12.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Figueroa Gray, Marlaine
Banegas, Matthew P
Henrikson, Nora B
Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title_full Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title_fullStr Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title_full_unstemmed Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title_short Conceptions of Legacy Among People Making Treatment Choices for Serious Illness: Protocol for a Scoping Review
title_sort conceptions of legacy among people making treatment choices for serious illness: protocol for a scoping review
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789496/
https://www.ncbi.nlm.nih.gov/pubmed/36485023
http://dx.doi.org/10.2196/40791
work_keys_str_mv AT figueroagraymarlaine conceptionsoflegacyamongpeoplemakingtreatmentchoicesforseriousillnessprotocolforascopingreview
AT banegasmatthewp conceptionsoflegacyamongpeoplemakingtreatmentchoicesforseriousillnessprotocolforascopingreview
AT henriksonnorab conceptionsoflegacyamongpeoplemakingtreatmentchoicesforseriousillnessprotocolforascopingreview